The healthcare sector has struggled to deliver worthwhile returns for investors since 2021, weighed down by several headwinds ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Is Alnylam Pharmaceuticals (ALNY) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Alnylam Pharmaceuticals is one of 1010 individual ...

President Donald Trump is pulling the U.S. out of the World Health Organization, raising concerns about the U.N. agency's ...

Neuren Pharmaceuticals' (ASX:NEU) stock is up by a considerable 13% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this ...

Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...

Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case? These companies make drugs ...

In follow up to the State Administration for Market Regulation’s (SAMR) draft of August 9, 2024, China’s State Council has ...

The company reported revenue of $22.5 billion and adjusted earnings of $2.04 per share, compared to the consensus estimates ...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a leading biotechnology company specializing in cystic fibrosis (CF) treatments, has been making significant strides in expanding its therapeutic portfolio ...

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to ...